itacitinib — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-22 today
ESTIMATED |
READOUT
A Rollover Study to Provide Continued Treatment for Participants Previously Enro
Phase 2 · Myelofibrosis, Postlung Transplant (Bronchiolitis Obliterans) |
INCY INCYTE CORP | itacitinib |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|